Among patients with diabetes mellitus, women more frequently used statins (67.7 vs. 42.4%; p=0.042) and angiotensin II type 1 receptor blockers (58.1 vs. 27.3%; p=0.013). This evidence concerns the gene AGTR1 and diabetes mellitus.